Michael Anthony Roth
CIK 1010207 · last filed 2011-11-14
Michael Anthony Roth is a corporate insider who has filed 56 SEC Form 4 insider transactions across 8 companies since 2007. Across all open-market trades the lifetime net is −$63.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.5M across reported positions. 164 SEC filings were submitted jointly with BRIAN JAY STARK.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$42.54M
8
56
-$63.88M
Filer Profile
ST. FRANCIS, WI 53235
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Fibrocell Science, Inc. (ILE) Delisted | 10%+ Owner | 6,656,839 | — | — | -$428.9K | 8 | 2009-04-29 |
| NORTH AMERICAN SCIENTIFIC INC (NASM) Delisted | 10%+ Owner | 2,853,084 | — | — | -$14.3K | 3 | 2009-03-06 |
| PLANETOUT INC (LGBT) Delisted | 10%+ Owner | 538,521 | $26.61 | $14.33M | -$12.9K | 4 | 2009-03-03 |
| Acer Therapeutics Inc. (OPXAW) Delisted | 10%+ Owner | 360,174 | — | — | -$287.2K | 1 | 2008-09-23 |
| MFLX | 10%+ Owner | 2,561,192 | $16.61 | $42.54M | -$45.61M | 18 | 2008-06-30 |
| BOULDER BRANDS, INC. (SMBLW) Delisted | 10%+ Owner | 1,776,746 | — | — | -$17.25M | 8 | 2007-09-19 |
| CRY | 10%+ Owner | — | $17.45 | — | $0 | 1 | 2007-07-10 |
| UROPLASTY INC (UPI) Delisted | 10%+ Owner | 1,407,462 | — | — | -$267.6K | 1 | 2007-03-07 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-11-14 | — | Sell (S) | −10,000 | -$300 | |
| 2011-11-03 | — | Sell (S) | −55,000 | -$1.4K | |
| 2011-11-02 | — | Sell (S) | −10,000 | -$300 | |
| 2010-06-14 | — | Sell (S) | −1,020,042 | -$40.8K | |
| 2009-07-08 | — | Sell (S) | −2,515,808 | -$16.7K | |
| 2009-04-29 | Fibrocell Science, Inc. (ILE) Delisted | Sell (S) | −42,200 | -$6.0K | EDGAR |
| 2009-04-29 | — | Sell (S) | −2,000 | -$40 | |
| 2009-04-21 | — | Sell (S) | −20,000 | -$410 | |
| 2009-04-07 | — | Sell (S) | −582,148 | -$11.6K | |
| 2009-04-06 | Fibrocell Science, Inc. (ILE) Delisted | Sell (S) | −134,000 | -$20.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.